Between 2024 and 2025, the number of pharmacists seeking a specialty credential more than doubled, rising from 3,058 to 6,681. The Board of Pharmacy Specialties announced Jan. 28 the pass rates for 14 pharmacy specialty certification exams. Of the 6,681…
Pharmacy
Walmart has moved 3,000 of its pharmacy technicians into pharmacy operations team lead roles and expanded pay ranges for the workforce. Pharmacy technician hourly rates average $22, which can increase to $40.50 depending on location and certification, according to a…
The Trump administration filed a motion Jan. 27 asking a federal court in Louisiana to pause a lawsuit that seeks to reimpose restrictions on the abortion pill mifepristone while the FDA conducts a new review of the drug’s safety and…
The Department of Health and Human Services issued a special advisory bulletin clarifying that pharmaceutical manufacturers may sell lower-cost prescription drugs directly to Medicare and Medicaid patients without violating the Anti-Kickback Statute, provided that specific safeguards are met. The guidance,…
Eli Lilly has entered a global research collaboration and licensing agreement with Seamless Therapeutics to develop programmable recombinase-based gene therapies for genetic hearing loss. Under the deal, Lilly secured exclusive rights to site-specific recombinases programmed by Seamless to target gene…
Advertisement
More than 850,000 members of Horizon NJ Health, the managed Medicaid plan operated by Horizon Blue Cross Blue Shield of New Jersey, will lose in-network access to CVS pharmacies after April 30. The insurer is advising affected members to transfer…
CMS will negotiate the prices for Trulicity, Biktarvy and 13 other high-cost medications commonly covered by Medicaid Parts B and D, according to a Jan. 27 news release from the agency. The Medicare Drug Price Negotiation Program enacted its first…
The FDA has accepted Otsuka’s New Drug Application for centanafadine, a first-in-class norepinephrine, dopamine and serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit hyperactivity disorder across all age groups. Centanafadine is being reviewed under priority status, with a Prescription…
As cell and gene therapies move into mainstream care, pharmacy leaders say health systems are confronting a shared reality: While they may be clinically prepared, their infrastructure might be insufficient — especially in terms of financing, coordination and sustainability for…
The 340B program stands at a critical crossroads in 2026. With the recent court-ordered pause of the rebate pilot program and HHS’s decision to “go back to the drawing board,” covered entities have gained valuable breathing room, but fundamental challenges…